Molecular and functional MDR1-PGP and MRPs expression in human glioblastoma multiforme cell lines

被引:71
作者
Declèves, X
Fajac, A
Lehmann-Che, J
Tardy, M
Mercier, C
Hurbain, I
Laplanche, JL
Bernaudin, JF
Scherrmann, JM
机构
[1] Hop Fernand Widal, INSERM, U26, Paris, France
[2] Univ Paris 06, Hop Tenon, Lab Histol Biol Tumorale, Paris, France
[3] Fac Med Paris 12, INSERM, U421, Creteil, France
[4] Hop Lariboisiere, Serv Biochim & Biol Mol, F-75475 Paris, France
关键词
P-glycoprotein; MRP; glioblastoma multiforme; GL15; 8MG;
D O I
10.1002/ijc.10135
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of our study was to investigate the functional expression of P-glycoprotein (Pgp) and multidrug resistance-associated proteins (MRPs) in 2 distinct glioma cells (GL15 and 8MG) from patients with glioblastoma multiforme. MDR1 gene and Pgp expression was not detected in either cell line by RT-PCR and Western blotting, respectively. In contrast, MRP1 was detected at both mRNA and protein level in both cell lines, with a higher expression in the 8MG cells that occur predominantly at the cell membrane. Three other MRPs (MRP3, MRP4 and MRP5) were detected by RTPCR in both cell lines, whereas MRP2 was not expressed. In addition, MRP3 protein was also detected by immunocytochemistry in both GL15 and 8MG cell lines. Indomethacin and probenecid, 2 modulators of MRPs activity, increased the accumulation of vincristine and etoposide, 2 substrates of MRPs, by both cell lines. These modulators also decreased the efflux of vincristine from both cell lines with a more pronounced effect in 8MG cells. In conclusion, our results show functional expression of MRPs leading to a decrease in the intracellular vincristine and etoposide concentrations in human glioblastoma cell lines. Furthermore, our results that exhibit protein expression of MRP1 and MRP3 and gene expression of MRP4 and MRP5 in these 2 glioblastoma cell lines suggest new mechanisms that could lead to a MDR phenotype of tumour cells in patients with glioblastoma multiforme. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 50 条
  • [41] CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies
    Engman, HA
    Lennernäs, H
    Taipalensuu, J
    Otter, C
    Leidvik, B
    Artursson, P
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (11) : 1736 - 1751
  • [42] Retroviral transfer and expression of human MDR-1 in a murine haemopoietic stem cell line does not alter factor dependence, growth or differentiation characteristics
    CM Heyworth
    D Gagen
    KG Edington
    LJ Fairbairn
    Leukemia, 2002, 16 : 106 - 111
  • [43] Acetaminophen-induced stimulation of MDR1 expression and activity in rat intestine and in LS 174T human intestinal cell line
    Ghanem, Carolina I.
    Arias, Agostina
    Novak, Analia
    Carpini, Griselda Delli
    Villanueva, Silvina
    Blazquez, Alba G.
    Marin, Jose J. G.
    Mottino, Aldo D.
    Rubio, Modesto C.
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (02) : 244 - 250
  • [44] Retroviral transfer and expression of human MDR-1 in a murine haemopoietic stem cell line does not after factor dependence, growth or differentiation characteristics
    Heyworth, CM
    Gagen, D
    Edington, KG
    Fairbairn, LJ
    LEUKEMIA, 2002, 16 (01) : 106 - 111
  • [45] Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines
    Brossard, Dominique
    El Kihel, Laila
    Clement, Monique
    Sebbahi, Walae
    Khalid, Mohamed
    Roussakis, Christos
    Rault, Sylvain
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (07) : 2912 - 2918
  • [46] The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines
    B C Medeiros
    H J Landau
    M Morrow
    R O Lockerbie
    T Pitts
    S G Eckhardt
    Leukemia, 2007, 21 : 739 - 746
  • [47] The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines
    Medeiros, B. C.
    Landau, H. J.
    Morrow, M.
    Lockerbie, R. O.
    Pitts, T.
    Eckhardt, S. G.
    LEUKEMIA, 2007, 21 (04) : 739 - 746
  • [48] Differential expression of sphingolipids in P-glycoprotein or multidrug resistance-related protein 1 expressing human neuroblastoma cell lines
    Dijkhuis, AJ
    Douwes, J
    Kamps, W
    Sietsma, H
    Kok, JW
    FEBS LETTERS, 2003, 548 (1-3): : 28 - 32
  • [49] pH and drug resistance.: I.: Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines
    Martínez-Zaguilán, R
    Raghunand, N
    Lynch, RM
    Bellamy, W
    Martinez, GM
    Rojas, B
    Smith, D
    Dalton, WS
    Gillies, RJ
    BIOCHEMICAL PHARMACOLOGY, 1999, 57 (09) : 1037 - 1046
  • [50] L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines
    Chiu, Ling-Yen
    Ko, Jiunn-Liang
    Lee, Yi-Ju
    Yang, Tsung-Ying
    Tee, Yi-Torng
    Sheu, Gwo-Tarng
    TOXICOLOGY LETTERS, 2010, 192 (03) : 408 - 418